Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.85
Bid: 17.00
Ask: 18.70
Change: 0.00 (0.00%)
Spread: 1.70 (10.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 17.85
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Tue, 26th Oct 2021 16:03

Wednesday 27 October 
Aveva Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
ContourGlobal PLCTrading Statement
Fresnillo PLCQ3 Production Results
GlaxoSmithKline PLCQ3 Results
RPS Group PLCTrading Statement
Wickes Group PLCTrading Statement
Thursday 28 October 
Airtel Africa PLCHalf Year Results
Bytes Technology Group PLCHalf Year Results
C&C Group PLCHalf Year Results
DS Smith PLCTrading Statement
Elementis PLCTrading Statement
Evraz PLCQ3 Results
Gem Diamonds LtdQ3 Trading Update
HarbourVest Global Private Equity LtdHalf Year Results
Helios Towers PLCQ3 Results
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
Indivior PLCQ3 Results
Lloyds Banking Group PLCQ3 Results
LMS Capital PLCTrading Statement
PPHE Hotel Group LtdQ3 Trading Update
Royal Dutch Shell PLCQ3 Results
Travis Perkins PLCQ3 Results
Virgin Wines UK PLCFull Year Results
WPP PLCTrading Statement
Friday 29 October 
Bank of Ireland Group PLCTrading Statement
Computacenter PLCTrading Statement
ConvaTec Group PLCTrading Statement
Glencore PLCQ3 Production Results
Grit Real Estate Income Group LtdFull Year Results
Industrials REIT LtdTrading Statement
International Biotechnology Trust PLCFull Year Results
NatWest Group PLCQ3 Results
Scancell Holdings PLCFull Year Results
Time Out Group PLCFull Year Results
Monday 1 November 
Brighton Pier Group PLCFull Year Results
K3 Capital Group PLCFull Year Results
Lok'n Store Group PLCFull Year Results
Ryanair Holdings PLCHalf Year Results
Tuesday 2 November 
Beximco Pharmaceuticals LtdFull Year Results
BP PLCQ3 Results
FD Technologies PLCHalf Year Results
Flutter Entertainment PLCQ3 Results
Hiscox LtdTrading Statement
IWG PLCTrading Statement
Oncimmune Holdings PLCFull Year Results
Shepherd Neame LtdFull Year Results
Standard Chartered PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
28 Feb 2022 14:41

Oncimmune signs new contract with Alphabet division Verily

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced the signing of a new commercial contract with Verily Life Sciences on Monday, a member of Google owner Alphabet's stable, focusing on the autoantibody profiling of patients who had Covid-19 and gone on to develop long lasting symptoms for more than four weeks, or 'long Covid'.

Read more
17 Feb 2022 22:13

TRADING UPDATES: Novacyt gets UK approval; Nostra spuds Cypress well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:

Read more
17 Feb 2022 09:09

Oncimmune's EarlyCDT Lung test granted approval by Ministry of Health for Aragon

(Sharecast News) - Immunodiagnostics group Oncimmune Holdings said on Thursday that its EarlyCDT Lung test had been granted approval by the Ministry of Health for Aragon in Spain and will now be adopted in the University Hospital Miguel Servet in Zaragoza.

Read more
15 Feb 2022 22:16

TRADING UPDATES: Burford, Frenkel Topping expect contrasting results

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
31 Dec 2021 11:20

Oncimmune reports fresh research from Cedars-Sinai Covid study

(Sharecast News) - Oncimmune announced the publication of a paper arising from the research collaboration with Cedars-Sinai Medical Center in Los Angeles on Friday, focusing on the sex-specific autoimmune reactivity to SARS-CoV-2 - the virus which causes Covid-19 - following mildly symptomatic infection.

Read more
31 Dec 2021 08:32

Oncimmune study suggests antibodies spike following Covid infection

Oncimmune study suggests antibodies spike following Covid infection

Read more
21 Dec 2021 14:25

Oncimmune shares up after multiple commercial contract wins

Oncimmune shares up after multiple commercial contract wins

Read more
21 Dec 2021 13:07

Oncimmune signs new commercial contracts

(Sharecast News) - Oncimmune Holdings announced on Tuesday that it has signed further commercial contracts within its 'ImmunoINSIGHTS' pharma services business.

Read more
19 Nov 2021 16:06

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
2 Nov 2021 15:55

TRADING UPDATES: Annual profit rises for UP Global Sourcing, Beximco

TRADING UPDATES: Annual profit rises for UP Global Sourcing, Beximco

Read more
2 Nov 2021 09:57

AIM WINNERS & LOSERS: Warpaint sees profit topping market forecasts

AIM WINNERS & LOSERS: Warpaint sees profit topping market forecasts

Read more
29 Oct 2021 15:57

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

Read more
20 Sep 2021 13:47

Oncimmune inks profiling contract with unnamed global pharma company

Oncimmune inks profiling contract with unnamed global pharma company

Read more
20 Sep 2021 11:24

Oncimmune inks deal with global pharma firm

(Sharecast News) - Immunodiagnostics company Oncimmune has signed an autoantibody profiling agreement with an unnamed global pharmaceutical company, it announced on Monday, to evaluate the autoantibody profiles of patient samples in various autoimmune diseases.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.